Total Knee Arthroplasty and Augmented Reality-based Navigation System
Launched by ELSAN · Jan 31, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new technology called an augmented reality-based navigation system to help improve the accuracy of Total Knee Replacement (TKR) surgeries for patients with gonarthrosis, which is a painful condition affecting the knee. The goal is to see if this new system can align and position the artificial knee parts as well as or better than traditional methods, which could lead to better recovery and knee function after surgery. The trial will also look at whether using this technology is cost-effective compared to standard techniques.
To be eligible for the study, participants must be at least 18 years old and diagnosed with gonarthrosis affecting a specific type of knee alignment, requiring a Total Knee Replacement. However, certain conditions, like having a history of specific knee surgeries or other significant joint issues, would exclude someone from participating. Those who join the trial will have the opportunity to receive care using this innovative technology, and their experiences will help determine its effectiveness for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Gonarthrosis on a varum knee requiring a Total Knee Replacement
- • 2. Female or male, 18 years of age or older
- • 3. Affiliation to a social security scheme
- • 4. Patient has been informed of the study and has signed an informed consent form
- Exclusion Criteria:
- • 1. Osteonecrosis,
- • 2. Post traumatic osteoarthritis with femoral or tibial callus,
- • 3. History of tibial or femoral osteotomy,
- • 4. Valgum knee,
- • 5. Isolated patellofemoral osteoarthritis,
- • 6. Significant hip dysplasia or other excessive pelvic deformity,
- • 7. Patient already equipped with medical devices that may conflict with the instrumentation required for augmented reality navigation,
- • 8. Pregnant or breastfeeding women,
- • 9. Patients under legal protection.
About Elsan
Elsan is a leading healthcare organization specializing in the management and operation of private medical facilities, with a strong focus on enhancing patient care and clinical outcomes. With a commitment to innovation and excellence, Elsan conducts clinical trials that advance medical research and treatment options across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and researchers to ensure rigorous study design and ethical standards, ultimately aiming to contribute valuable insights to the medical community and improve patient health on a broader scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurillac, , France
Patients applied
Trial Officials
Frédéric Dalat, MD
Principal Investigator
Centre Médico-Chirurgical de Tronquières
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials